Single-cell analysis has moved from academic curiosity to clinical necessity. At Shenzhen BioX Medical Co., Ltd., we bridge the gap between complex genetic data and actionable clinical insights. Since 2017, we have pioneered manufacturing workflows that provide CE-certified reliability for global laboratories.
The transition toward personalized medicine is driving demand for high-throughput, automated single-cell solutions.
We are integrating AI-driven data processing into our hardware to reduce time-to-result by 40%.
From oncology research to infectious disease monitoring, our systems provide the sensitivity required for modern diagnostics.
Compliance ensures that your lab meets international safety and performance benchmarks, critical for clinical validation.
Yes, we provide flexible customization to help distributors and healthcare brands scale their molecular diagnostic portfolios.
The industry is trending toward point-of-care (POC) testing and decentralized lab workflows for faster patient care.
Contact us for custom Molecular Diagnostic manufacturing requirements.
BioX Medical
